DAPAFLOZIN 5

Dapaflozin 5 mg is an oral antidiabetic medication that belongs to the SGLT2 inhibitor class (Sodium-Glucose Co-Transporter 2 inhibitors). It helps control blood sugar levels in adults with Type 2 Diabetes Mellitus by promoting the removal of excess glucose through urine. This medicine not only supports glycemic control but may also aid in weight loss and blood pressure reduction.

Key Benefits:

• Reduces blood sugar levels effectively in Type 2 Diabetes

• Promotes weight loss and lowers blood pressure

• Helps improve cardiovascular and kidney outcomes

• Low risk of hypoglycemia when used alone